申请人:Blaskovich Mark Arnold Thomas
公开号:US20110263572A1
公开(公告)日:2011-10-27
The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-5 receptor (MC5R). Compounds of this invention can be used to treat diseases and/or conditions in which downregulation of MC5R is beneficial. Such diseases and/or conditions include, but are not limited to, acne, seborrhea, seborrheic dermatitis, cancer, and inflammatory diseases.
本发明提供了公式(I)的化合物,它们对调节黑素细胞激素-5受体(MC5R)的生物活性有用。本发明的化合物可用于治疗下调MC5R有益的疾病和/或状况。这些疾病和/或状况包括但不限于痤疮、脂溢性皮炎、皮脂溢出、癌症和炎症性疾病。